Akoya BioSciences/AKYA

$2.90

3.94%
-
1D1W1MYTD1YMAX

About Akoya BioSciences

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Ticker

AKYA

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Brian McKelligon

Employees

330

Headquarters

Marlborough, United States
Website
www.akoyabio.com

AKYA Metrics

BasicAdvanced
$138M
Market cap
-
P/E ratio
-$1.47
EPS
-
Beta
-
Dividend rate
$138M
$8.80
$2.75
203K
3.068
2.375
232.567
234.762
-10.15%
-44.01%
-181.72%
-56.06%
1.471
4.207
17.89%
23.57%
31.55%

What the Analysts think about AKYA

Analyst Ratings

Majority rating from 8 analysts.
Buy

Price Targets

Average projection from 6 analysts.
130% upside
High $8.00
Low $6.00
$2.90
Current price
$6.67
Average price target

AKYA Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-127.86% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$18M
-30.68%
Net income
-$23M
116.67%
Profit margin
-127.86%
212.62%

AKYA Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 66.23%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.51
-$0.26
-$0.22
-$0.48
-
Expected
-$0.44
-$0.37
-$0.27
-$0.29
-$0.26
Surprise
15.16%
-28.91%
-18.08%
66.23%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Akoya BioSciences stock?

Akoya BioSciences (AKYA) has a market cap of $138M as of May 17, 2024.

What is the P/E ratio for Akoya BioSciences stock?

The price to earnings (P/E) ratio for Akoya BioSciences (AKYA) stock is 0 as of May 17, 2024.

Does Akoya BioSciences stock pay dividends?

No, Akoya BioSciences (AKYA) stock does not pay dividends to its shareholders as of May 17, 2024.

When is the next Akoya BioSciences dividend payment date?

Akoya BioSciences (AKYA) stock does not pay dividends to its shareholders.

What is the beta indicator for Akoya BioSciences?

Akoya BioSciences (AKYA) does not currently have a Beta indicator.

What is the Akoya BioSciences stock price target?

The target price for Akoya BioSciences (AKYA) stock is $6.67, which is 130% above the current price of $2.9. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Akoya BioSciences stock

Buy or sell Akoya BioSciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing